
Gilead appoints former Roche executive
pharmafile | September 9, 2016 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Gilead, Roche, appointment
Gilead Sciences has hired Rogers Luo as vice president and general manager of commercial operations in China. Luo formerly served as vice president at Shanghai Roche Pharmaceuticals.
His primary remit will be building the company’s commercial operations in China, preparing the potential launch of its hepatitis C and B treatments over the next few years.
Several of the firm’s drugs including Sovaldi remain unavailable to patients in the country thanks to a lengthy approval process which can cause years of delays. It will be Luo’s job to spearhead these issues in the region.
The Chinese Food and Drug Administration (CFDA) announced earlier this year that it seeking to revamp its processes, and noted that both Sovaldi and another Gilead product Harvoni would receive priority review, though it is not known how far away this may be.
Related Content

Roche secures CE Mark for automated latent tuberculosis blood test
Roche has received CE Mark approval for its Elecsys IGRA TB test, an automated blood …

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory
Roche has expanded its global AI infrastructure with a NVIDIA AI factory, adding 2,176 high-performance …

Gilead’s HIV treatment meets primary trial endpoint
Gilead has announced positive topline results from its phase 3 ARTISTRY-2 trial, which evaluated a …





